EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition

Yan Zhong, Chuang Xiao, Yaping Liang, Peng Wang, Yun Long, Shuyi Li, Na Song, Wenbin Shang, Weimin Yang, Xuan Zhang

Natural Products and Bioprospecting · 2026-12 · 16 (1)

DOI: 10.1007/s13659-026-00593-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Natural Products and Bioprospecting, online erschienen am 13.04.2026. Verfasst von Yan Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medica…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis (PF) is a chronic, progressive and irreversible inflammatory disease with limited therapeutic methods in clinic. Deacetylforskolin (DFSK), derived from the plant Coleus forskohlii , is a potent adenylyl cyclase activator with potential anti-inflammatory activity. Herein, we attempted to investigate the therapeutic potential and mechanisms of DFSK against PF in bleomycin (BLM)-induced mouse models and TGF-β1-induced A549 cells. Our results showed that DFSK treatment alleviated lung injury and reduced inflammatory cytokines in a mouse model of BLM-induced acute lung inflammation, an early stage of PF. In a BLM-induced PF mouse model, DFSK attenuated pathological lung injury and collagen deposition, decreased pro-inflammatory cytokines (TNF-α, IL-1β) and profibrotic mediators (TGF-β1, CTGF, hydroxyproline). Upregulation of the epithelial marker E-cadherin and downregulation of the mesenchymal marker α-SMA were observed following DFSK treatment. Furthermore, DFSK significantly restored the pulmonary function of PF mice with decreased Te, f, Penh and increased RT, TV. Mechanistically, DFSK suppressed the phosphorylation of JNK and p38 MAPK, and inhibited TGF-β1-induced epithelial–mesenchymal transition (EMT) in A549 cells. Collectively, our findings demonstrate that DFSK is an effective therapeutic agent against PF by suppressing inflammation and EMT. Graphical Abstract

Schlagwörter

Stichwörter der Autor:innen

DeacetylforskolinEpithelial–mesenchymal transitionInflammationMAPK signalingPulmonary fibrosis

Autor:innen und Institutionen

  • School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China.
  • The People's Hospital of Dechang County, Liangshan Yi Autonomous Prefecture, Sichuan, 615500, China.
  • School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. shangwenbin@kmmu.edu.cn.
  • School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. ywmbessie@yeah.net.
  • School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, Kunming Medical University, Kunming, 650500, China. zhangxuan@kmmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Yunnan Provincial Science and Technology Department

Zitieren

APA

Zhong, Y., Xiao, C., Liang, Y., Wang, P., Long, Y., Li, S., Song, N., Shang, W., Yang, W., & Zhang, X. (2026). Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition. Natural Products and Bioprospecting, 16(1). https://doi.org/10.1007/s13659-026-00593-4

Vancouver

Zhong Y, Xiao C, Liang Y, Wang P, Long Y, Li S, et al. Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition. Natural Products and Bioprospecting. 2026;16(1). doi:10.1007/s13659-026-00593-4

BibTeX
@article{Zhong2026,
  author = {Zhong, Yan and Xiao, Chuang and Liang, Yaping and Wang, Peng and Long, Yun and Li, Shuyi and Song, Na and Shang, Wenbin and Yang, Weimin and Zhang, Xuan},
  title = {Deacetylforskolin ameliorates bleomycin-induced pulmonary fibrosis by suppressing inflammation and TGF-β1-induced epithelial–mesenchymal transition},
  journal = {Natural Products and Bioprospecting},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.1007/s13659-026-00593-4}
}
Kostenlos starten →